Financials

  • Market Capitalization 714.39 M
  • Employee 22
  • Founded 2014
  • CEO N/A
  • Website www.monopartx.com
  • Headquarter Delaware, United States
  • FIGI BBG00J7K8D90
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-35.28
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2676
CADL
Candel Therapeutics, Inc. - Common Stock
10.03 USD+4.05%+2.77%+15.29%+54.31%734.90 M USD
2711
RLMD
Relmada Therapeutics, Inc. - Common Stock
6.41 USD-0.62%-2.14%-3.90%+950.82%672.35 M USD
2720
BBOT
BridgeBio Oncology Therapeutics, Inc. - Common Stock
8.92 USD+4.69%+7.34%+14.36%-6.01%714.56 M USD
2736
ALLO
Allogene Therapeutics, Inc. - Common Stock
1.87 USD-3.11%-11.79%-3.11%+44.96%645.44 M USD

Nouvelles